APP and Alzheimer disease: Specifically, investigations using different dosages of THC and CBD in the APP-NL-G-F mouse model of AD have revealed no significant effect on memory-related behavioral tasks or inflammation (Nixon et al., 2022), and a combination of cannabis extract used to improve pathology or memory deficits in the same mouse model has also shown no effect (Robinson et al., 2023).